From Monday the national roll out of tirzepatide (Brand name Mounjaro®) for the management of obesity begins.
We anticipate a lot of demand for this BUT there is a nationally set roll-out programme which limits eligibility for many years.
Every year additional patients become eligible but for the first year only a tiny number of patients are eligible – only 0.1% of our patients have been identified as meeting the criteria for this year.
The eligibility for this year is ONLY if you have a BMI of 40 or over AND have four or more of the following health conditions:
• type 2 diabetes,
• high blood pressure,
• high cholesterol,
• sleep apnoea,
• cardiovascular disease
AND a clinician considers it appropriate treatment.
The vast majority of our patients do not currently fit this criteria and if you don’t fit the criteria we cannot offer you this medication this year. We are not allowed to prescribe outside of the set roll-out programme.
We will publicise the changes each year – but note it is a ten year roll-out programme.
In the meantime we recommend you book to see our health coaches – who have had great success helping patients – Forms – Somerset Activity & Sports Partnership
Read full details about Mounjaro here: